NCT01838317View on ClinicalTrials.gov

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

September 20, 2017

Study Completion Date

September 20, 2017

Conditions
Cancer of the Pancreas
Interventions
DRUG

Pioglitazone

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT01838317 - A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas | Biotech Hunter | Biotech Hunter